title: The EPOS-CC Score: An Integration of Independent, Tumor- and Patient-Associated Risk Factors to Predict 5-years Overall Survival Following Colorectal Cancer Surgery.
abstract: BACKGROUND
  Surgical audit is an essential task for the estimation of postoperative outcome and comparison of quality of care. Previous studies on surgical audits focused on short-term outcomes, such as postoperative mortality. We propose a surgical audit evaluating long-term outcome following colorectal cancer surgery. The predictive model for this audit is designated as 'Estimation of Postoperative Overall Survival for Colorectal Cancer (EPOS-CC)'.
  
  
  METHODS
  Thirty-one tumor-related and physiological variables were prospectively collected in 889 patients undergoing elective resection for colorectal cancer between April 2005 and April 2007 in 16 Japanese hospitals. Postoperative overall survival was assessed over a 5-years period. The EPOS-CC score was established by selecting significant variables in a uni- and multivariate analysis and allocating a risk-adjusted multiplication factor to each variable using Cox regression analysis. For validation, the EPOS-CC score was compared to the predictive power of UICC stage. Inter-hospital variability of the observed-to-estimated 5-years survival was assessed to estimate quality of care.
  
  
  RESULTS
  Among the 889 patients, 804 (90%) completed the 5-years follow-up. Univariate analysis displayed a significant correlation with 5-years survival for 14 physiological and nine tumor-related variables (p < 0.005). Highly significant p-values below 0.0001 were found for age, ASA score, severe pulmonary disease, respiratory history, performance status, hypoalbuminemia, alteration of hemoglobin, serum sodium level, and for all histological variables except tumor location. Age, TNM stage, lymphatic invasion, performance status, and serum sodium level were independent variables in the multivariate analysis and were entered the EPOS-CC model for the prediction of survival. Risk-adjusted multiplication factors between 1.5 (distant metastasis) and 0.16 (serum sodium level) were accorded to the different variables. The predictive power of EPOS-CC was superior to the one of UICC stage; area under the curve 0.87, 95% CI 0.85-0.90 for EPOS-CC, and 0.80, 0.76-0.83 for UICC stage, p < 0.001. Quality of care did not differ between hospitals.
  
  
  CONCLUSIONS
  The EPOS-CC score including the independent variables age, performance status, serum sodium level, TNM stage, and lymphatic invasion is superior to the UICC stage in the prediction of 5-years overall survival. This higher accuracy might be explained by the inclusion of physiological factors, thus also taking non-tumor-associated deaths into account. Furthermore, EPOS-CC score may compare quality of care among different institutions. Future studies are necessary to further evaluate this score and help improving the prediction of long-term survival following colorectal cancer surgery.
authors: Institute for Clinical Research, National Hospital Organization Kumamoto Medical Center, 1-5 Ninomaru, Chuo-Ku, Kumamoto, 8600008, Japan, yoshio@kumamed.jp.
authors: Yoshio
authors: Y
authors: Haga
authors: Koji
authors: K
authors: Ikejiri
authors: Yasuo
authors: Y
authors: Wada
authors: Masakazu
authors: M
authors: Ikenaga
authors: Shoichiro
authors: S
authors: Koike
authors: Seiji
authors: S
authors: Nakamura
authors: Masato
authors: M
authors: Koseki
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D019540:Area Under Curve; D015179:Colorectal Neoplasms / Q000401:mortality / Q000473:pathology* / Q000503:physiopathology / Q000601:surgery*; D017558:Elective Surgical Procedures; D005260:Female; D006305:Health Status Indicators; D006801:Humans; D042601:Lymphatic Vessels / Q000473:pathology; D008297:Male; D008485:Medical Audit; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D012372:ROC Curve; D012307:Risk Factors; D012964:Sodium / Q000097:blood; D015996:Survival Rate
chemical_list: D012964:Sodium
references: Br J Anaesth. 2012 Mar;108(3):430-5
references: 22258201
references: Int J Colorectal Dis. 2011 Apr;26(4):473-81
references: 21190025
references: Ann Surg. 2008 Aug;248(2):329-36
references: 18650645
references: Gastric Cancer. 2015 Jan;18(1):138-46
references: 24500678
references: Jpn J Clin Oncol. 2011 Oct;41(10):1203-8
references: 21940733
references: J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):599-606
references: 24648305
references: Surg Today. 1999;29(3):219-25
references: 10192731
references: Ann Surg. 2008 Jan;247(1):125-35
references: 18156932
references: World J Surg. 2007 Jul;31(7):1485-90
references: 17510767
references: Ann Surg. 2007 Aug;246(2):222-8
references: 17667500
references: Int J Colorectal Dis. 2014 Aug;29(8):971-9
references: 24924447
references: Dis Colon Rectum. 2011 Oct;54(10):1293-300
references: 21904145
references: J Am Coll Surg. 2013 Dec;217(6):1090-100
references: 24045143
references: Dis Colon Rectum. 2006 Jun;49(6):825-32
references: 16550320
references: World J Surg. 2014 May;38(5):1177-83
references: 24322176
references: Gastric Cancer. 2012 Jan;15(1):7-14
references: 21538017
references: Arch Surg. 2002 Apr;137(4):481-5
references: 11926959
references: Surgery. 2004 Jun;135(6):586-94
references: 15179364
references: J Clin Oncol. 2005 Dec 1;23(34):8706-12
references: 16314630
references: Ann Surg. 2011 Jan;253(1):194-201
references: 21233616
references: J Surg Oncol. 2012 Dec;106(7):898-904
references: 22605669
references: Am J Surg. 2013 Nov;206(5):758-63
references: 23835209
references: Ann Surg. 2002 Sep;236(3):344-53; discussion 353-4
references: 12192321
references: World J Surg. 2013 Aug;37(8):1808-13
references: 23703637
references: Public Health Rep. 2011 Jul-Aug;126(4):460-71
references: 21800741
references: World J Surg. 2012 Feb;36(2):424-30
references: 22187130
references: World J Surg. 2013 May;37(5):1094-102
references: 23385643
references: Br J Surg. 1991 Mar;78(3):355-60
references: 2021856
references: Ann Surg. 1998 Oct;228(4):491-507
references: 9790339
references: Ann Surg. 2009 Aug;250(2):187-96
references: 19638912
references: J Surg Oncol. 2011 Sep 1;104(3):284-91
references: 21462192
references: J Clin Oncol. 2008 Jan 20;26(3):380-5
references: 18202413